Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Pidilite Industries Limited, together with its subsidiaries, engages in the manufacture and sale of consumer and specialty chemicals in India and internationally. The company operates in two segments Branded Consumer & Bazaar, and Business to Business. The Branded Consumer & Bazaar segment offers adhesives, sealants, art and craft materials; and construction and paint chemicals for use by carpenters, painters, plumbers, mechanics, households, students, offices, etc. The Business to Business segment provides industrial adhesives and resins, construction chemicals, organic pigments, pigment preparations, etc. for use in various industries, including packaging, joineries, textiles, paints, printing inks, paper, leather, etc. It sells its products primarily under the Fevicol, Fevicol MR, Dr. Fixit, Fevikwik, M-Seal, Fevistick, Fevicryl, Fevigum, Rangeela, WD-40, MOTO MAX, Terminator, WUDFIN, HAI SHA, steelgrip, Araldite, Roff, and other brands. The company was founded in 1959 and is based in Mumbai, India.

Revenue projections:

Revenue projections for PIDILITIND
Revenue projections for PIDILITIND

With Pidilite Industries Limited's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 2.380000
forwardPE 52.532238
debtToEquity 3.776000
earningsGrowth 0.370000
revenueGrowth 0.141000
grossMargins 0.555570
operatingMargins 0.205330
trailingEps 24.000000
forwardEps 30.400380

PIDILITIND's current ratio of 2.38 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, PIDILITIND can comfortably cover its liabilities, reflecting a strong financial outlook.
PIDILITIND's high forward PE ratio signals potential overvaluation, limiting further price gains and increasing the risk of a correction. This metric should be carefully considered alongside other key fundamentals to assess the stock's future performance.
PIDILITIND's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
With positive gross and operating margins, PIDILITIND's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.
PIDILITIND's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with PIDILITIND anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for PIDILITIND
Price projections for PIDILITIND

PIDILITIND's price has consistently been situated near the lower end of expected values. This ongoing trend may reflect investor skepticism about the company's growth potential and overall performance.

Recommendation changes over time:

Recommendations trend for PIDILITIND
Recommendations trend for PIDILITIND


PIDILITIND has recently received a buy bias from analysts, indicating that the stock is being perceived as a favorable investment. This positive sentiment could encourage investors to see PIDILITIND as a wise place to allocate their funds, potentially leading to increased interest in the company's stock.